P-320 Iberdomide (IBER) Plus Dexamethasone (DEX) in Patients with Relapsed/refractory Multiple Myeloma (RRMM): a Safety Analysis from the CC-220-MM-001 Trial
Clinical Lymphoma Myeloma and Leukemia(2023)
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined